Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
16.89
-0.82 (-4.63%)
At close: Jan 30, 2026, 4:00 PM EST
17.22
+0.33 (1.95%)
After-hours: Jan 30, 2026, 5:43 PM EST
Simulations Plus Revenue
Simulations Plus had revenue of $18.42M in the quarter ending November 30, 2025, a decrease of -2.66%. This brings the company's revenue in the last twelve months to $78.68M, up 5.69% year-over-year. In the fiscal year ending August 31, 2025, Simulations Plus had annual revenue of $79.18M with 13.09% growth.
Revenue (ttm)
$78.68M
Revenue Growth
+5.69%
P/S Ratio
4.32
Revenue / Employee
$369,371
Employees
213
Market Cap
340.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 79.18M | 9.17M | 13.09% |
| Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
| Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
| Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
| Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
| Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
| Aug 31, 2019 | 33.97M | 4.30M | 14.51% |
| Aug 31, 2018 | 29.67M | 5.53M | 22.90% |
| Aug 31, 2017 | 24.14M | 4.17M | 20.86% |
| Aug 31, 2016 | 19.97M | 1.66M | 9.05% |
| Aug 31, 2015 | 18.31M | 6.85M | 59.80% |
| Aug 31, 2014 | 11.46M | 1.39M | 13.80% |
| Aug 31, 2013 | 10.07M | 622.16K | 6.58% |
| Aug 31, 2012 | 9.45M | 709.87K | 8.12% |
| Aug 31, 2011 | 8.74M | -1.97M | -18.42% |
| Aug 31, 2010 | 10.71M | 1.57M | 17.16% |
| Aug 31, 2009 | 9.14M | 175.30K | 1.95% |
| Aug 31, 2008 | 8.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolent Health | 2.05B |
| Claritev | 951.00M |
| TruBridge | 347.27M |
| Definitive Healthcare | 242.28M |
| Weave Communications | 229.79M |
| So-Young International | 201.13M |
| Spok Holdings | 139.74M |
| National Research | 139.10M |
SLP News
- 10 days ago - Simulations Plus, Inc. (SLP) Analyst/Investor Day Transcript - Seeking Alpha
- 10 days ago - Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day - Business Wire
- 23 days ago - Simulations Plus, Inc. (SLP) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Simulations Plus Reports First Quarter Fiscal 2026 Financial Results - Business Wire
- 6 weeks ago - Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Business Wire
- 6 weeks ago - Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date - Business Wire
- 7 weeks ago - Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions - Business Wire
- 2 months ago - Simulations Plus: Buying On Long-Term Silico Drug-Development - Seeking Alpha